"I cannot begin to express my appreciation for a job well done and the continued efforts you place to ensure that this study was a success! Your candor and transparency has been refreshing and I am fortunate to have partnered with such a great group of patient recruitment and retention experts! You are wonderful!
"I wanted to take a moment and say thank you for continuing to do a great job and meeting our expectations. I could not be more pleased with the teamwork and efficiency in which your team provided to our study!"
"It was a long journey, and we were all delighted with the successful outcome. We appreciate the support the CSSi Team provided along the way. Hopefully, we can work together again in the future."
Gene and cellular therapy are novel treatment methods that are avidly being studied in a realm of different indications including oncology, neurology, rheumatology, pediatrics, and more. As of 2023, there are over 1,500 gene/cellular therapy trials actively enrolling with a majority being in Phase 1 and Phase 2 stages.
Read More
LGBTQIA+ (Lesbian, Gay, Bisexual, Transgender, Queer, Intersexual, Asexual/Agender, + Additional Sexualities and Identities) make up a significant portion of the population: around 8% of the total United States population and an estimated 10% of the global population.1,2 Trends show an increased likelihood of identifying as LGBTQA+ in younger generations such as millennials and Gen Z.
Read More
Now that we have a flood of new adults entering the scene, they are eligible to participate in many clinical trials. These new adults aren’t their Millennial elders and are far removed from Gen X and the Baby Boomer generations, so new recruitment tactics and strategies need to be implemented to gain their interest.
Read More